A new drug combination may benefit men whose prostate cancer has returned after primary surgery or radiation therapy. Pairing enzalutamide, an androgen receptor blocker, with the hormone therapy drug ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...

SCIB1/iSCIB1+ combined with checkpoint inhibitors shows improved response rates and progression-free survival in advanced melanoma without added toxicity. The SCOPE trial's findings suggest a ...

As the newest and most advanced 2-in-1 vacuum and mop within iRobot's recently introduced suite of new Roomba robots, the Roomba Max 705 Combo conquers everyday messes - every day. At the heart of the ...

(RTTNews) - Takeda (TAK), Tuesday announced that the European Commission has approved ADCETRIS combined with etoposide, cyclophosphamide, doxorubicin, dacarbazine, and dexamethasone for newly ...

Samuraciclib, a CDK7 inhibitor, shows promise in HR-positive advanced breast cancer post-CDK4/6 inhibitor therapy, with extended PFS in specific patient groups. MORPHEUS and Module 2A trials highlight ...

At 3 years, Opdivo plus Yervoy led to an overall survival rate of 38% in patients with unresectable or metastatic hepatocellular carcinoma, compared to 24% with lenvatinib or sorafenib monotherapy.

FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer By Lori Solomon HealthDay Reporter TUESDAY, April 15, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

With advanced vacuuming, deep-scrub mopping, and a self-cleaning dock, this all-in-one robot keeps your floors spotless with minimal effort This article contains affiliate links from our advertisers.

"Welcome to GamingWithKev – epic gaming, crazy challenges, and nonstop fun. Follow along on Gaming Legends for more!" Barack Obama responds to Donald Trump's Russia "treason" threats US military ...

On Monday, the European Commission approved GSK plc’s (NYSE:GSK) Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult patients with ...